Patients may experience GI issues initially but that can be managed by adjusting the dose, says Dr
Moderate alcohol consumption, defined as up to one drink per day for women and up to two drinks per day for men, is generally considered acceptable for most patients, though individual tolerance and circumstances should be considered
However, the current literature reveals a lack of in vivo studies on specific GLP-1R agonists such as semaglutide, necessitating further research to elucidate its precise mechanisms and effects, particularly in cancer
Additionally, your doctor might explore transitioning you to more cost-effective oral medications, such as metformin or naltrexone/bupropion, to help you maintain your progress after tapering off completely
Zepbound (tirzepatide) is an FDA-approved medication for chronic weight management that works as a dual GIP and GLP-1 receptor agonist